A Phase 3, Multicenter, Open-Label Extension Trial of Oral RPC1063 as Therapy for Moderate to Severe Ulcerative Colitis
Principal Investigator
Baljinder SalhOverview
Study Start/End
Aug 16, 2016 to Dec 31, 2020Locations
Diamond Health Care Centre, Vancouver Community, Vancouver General Hospital
Name/Title
Jo-Ann E. Ford, Research Coordinator Phone
604-875-5705Email Address
joann.ford@vch.caPurpose of Study
The purpose of the trial is to determine the safety and efficacy of RPC1063 in patients diagnosed with moderate to severe ulcerative colitis.
Eligibility
Visit ClinicalTrials.gov for more information.
Disclaimer
Study Coordinators and Research Nurses cannot give medical advice over the phone. Telephone numbers and email addresses are provided for obtaining additional information on specific clinical research trials only. If you have specific questions which require clinical expertise, please call your primary care physician.